News

 

 

  • June 30, 2016 - BioSculpture Technology files its Form 1-A with the S.E.C. for a Tier 2 Regulation A Offering to fund development and clinical testing of its endoscopic treatment of obesity, metabolic syndrome and type 2 diabetes mellitus.

 

  • June 1-2, 2016 - For the second year in a row, BioSculpture Technology will present at Marcum's MicroCap conference at the Grand Hyatt in N.Y.C.

 

 

  • June 12, 2015 - Robert L. Cucin, CEO of BioSculpture Technology, Inc. appeared on the Bootstrapping Segment on tastytrade.com and discussed his personal journey and commitment to offering visceral lipectomy to the billions of people suffering from obesity, the anticipated regulatory pathway, a projected timeline, and the required resources to achieve this goal.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  • April 11,  2015 - Robert L. Cucin, M.D., the C.E.O. of BioSculpture Technology was interviewed on the I Heart Radio "Trader's Network Show.  He elaborates on the both the rationale and potential of the Endoscopic Visceral Lipectomy methods and devices under development.